Señales en vivo de KIN | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 dic 1970 @ 19:00):

Stats
Volumen de hoy	178 496
Volumen promedio	1.51M
Capitalización de mercado	0.00
EPS	$-0.200 ( 2021-08-05 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-9.09
ATR14	$0.0820 (0.89%)

Insider Trading

Date	Person	Action	Amount	type
2021-08-27	Park West Asset Management Llc	Sell	6 000 002	Common Stock, par value $0.0001 per share
2021-08-27	Wee Wendy	Sell	78 613	Common Stock
2021-08-27	Wee Wendy	Sell	32 500	Stock Option (right to buy)
2021-08-27	Wee Wendy	Sell	10 000	Stock Option (right to buy)
2021-08-27	Wee Wendy	Sell	75 000	Stock Option (right to buy)

INSIDER POWER
0.00
Last 100 transactions
Buy: 510 888 \| Sell: 9 693 361

Volumen Correlación

Largo: 0.19 (neutral)

Corto: -0.40 (neutral)

Signal:(69.694) Neutral

Kindred Biosciences, Inc. Correlación

10 Correlaciones Más Positivas
KRTX	0.986
FOCS	0.971
XM	0.963
BRAC	0.963
CRVL	0.961
MLVF	0.961
MDGL	0.96
ALGM	0.96
THRX	0.959
ACLS	0.958

10 Correlaciones Más Negativas
PIII	-0.973
PDBC	-0.973
UTME	-0.973
CYXT	-0.972
BIOL	-0.965
IMKTA	-0.962
MRBK	-0.958
SMFL	-0.958
SOLO	-0.956
CYAN	-0.952

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Kindred Biosciences, Inc. Correlación - Moneda/Commodity

0.45
( neutral )

0.73
( moderate )

-0.17
( neutral )

0.30
( neutral )

0.28
( neutral )

-0.71
( moderate negative )

Kindred Biosciences, Inc. Finanzas

Annual	2020
Ingresos:	$42.16M
Beneficio Bruto:	$37.54M (89.03 %)
EPS:	$-0.550

FY	2020
Ingresos:	$42.16M
Beneficio Bruto:	$37.54M (89.03 %)
EPS:	$-0.550

FY	2019
Ingresos:	$4.26M
Beneficio Bruto:	$3.67M (86.21 %)
EPS:	$-1.590

FY	2018
Ingresos:	$1.97M
Beneficio Bruto:	$1.64M (83.52 %)
EPS:	$-1.600

Financial Reports:

No articles found.

Kindred Biosciences, Inc.

Kindred Biosciences, Inc., a biopharmaceutical company, is developing biologics that focus on the lives of pets. The company has a pipeline of novel biologics in development across various therapeutic classes and intellectual property portfolio. Its programs under development include interleukin-31 and interleukin-4R for canine atopic dermatitis; KIND-030 for parvovirus in dogs; KIND-510a for the control of non-regenerative anemia in cats; anti-TNF antibody for inflammatory bowel disease in dogs; and other biologics candidates. The company was founded in 2012 and is headquartered in Burlingame, California.